| For: | Barazani SH, Chi WW, Pyzik R, Chang H, Jacobi A, O’Donnell T, Fayad ZA, Ali Y, Mani V. Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World J Radiol 2020; 12(8): 184-194 [PMID: 32913564 DOI: 10.4329/wjr.v12.i8.184] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v12/i8/184.htm |
| Number | Citing Articles |
| 1 |
P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina. NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management. Rational Pharmacotherapy in Cardiology 2024; 20(3) doi: 10.20996/1819-6446-2024-3018
|
| 2 |
Mariano Andrés, Leticia Mendieta, Elena Argente-Del-Castillo, Miguel Trigueros, Alberto Miñano, Eliseo Pascual. Birefringent crystals deposition and inflammasome expression in human atheroma plaques by levels of uricemia. Joint Bone Spine 2022; 89(5) doi: 10.1016/j.jbspin.2022.105423
|
| 3 |
G. Chalès, G. Coiffier, F. Robin. Gota y enfermedades cardiovasculares. EMC - Aparato Locomotor 2026; 59(1) doi: 10.1016/S1286-935X(26)51509-0
|
| 4 |
Ryan Warr, Stephan Handschuh, Martin Glösmann, Robert J. Cernik, Philip J. Withers. Quantifying multiple stain distributions in bioimaging by hyperspectral X-ray tomography. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23592-0
|
| 5 |
Jin Xu, Xiao Du, Shilan Zhang, Xueyan Zang, Zixi Xiao, Rongkai Su, Xiadie Huang, Ling Liu. Diagnostic value of uric acid to high-density lipoprotein cholesterol ratio in abdominal aortic aneurysms. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2357224
|
| 6 |
Muhammad Israr Ahmad, Salman Masood, Daniel Moreira Furlanetto, Savvas Nicolaou. Urate Crystals; Beyond Joints. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.649505
|
| 7 |
Michael H. Pillinger, Michael Toprover. The Fifth Element: Is Vascular Dysfunction an Intrinsic Feature of Gout?. Seminars in Arthritis and Rheumatism 2025; 72 doi: 10.1016/j.semarthrit.2025.152679
|
| 8 |
Nicole Leung, Charles Fang, Jay Pendse, Michael Toprover, Michael H. Pillinger. Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout. Current Rheumatology Reports 2023; 25(5) doi: 10.1007/s11926-023-01100-1
|
| 9 |
Hiroyuki Hashimoto, Masato Takeuchi, Koji Kawakami. Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia. Clinical Rheumatology 2023; 42(11) doi: 10.1007/s10067-023-06710-9
|
| 10 |
Hiroki Kondo, Akihito Tanaka, Shun Miyamoto, Hitomi Suzuki, Hikari Matsumoto, Shinichiro Takeda, Koji Mizutani, Kensuke Tagahara, Hiroto Uno, Kenji Furusawa, Hideki Ishii, Toyoaki Murohara. Impact of hyperuricemia on cardiac events in stable coronary artery disease patients with or without renal dysfunction. Heart and Vessels 2026; doi: 10.1007/s00380-026-02685-0
|
| 11 |
Andrea Sabine Klauser, Sylvia Strobl, Christoph Schwabl, Christian Kremser, Werner Klotz, Violeta Vasilevska Nikodinovska, Hannes Stofferin, Yannick Scharll, Ethan Halpern. Impact of Dual-Energy Computed Tomography (DECT) Postprocessing Protocols on Detection of Monosodium Urate (MSU) Deposits in Foot Tendons of Cadavers. Diagnostics 2023; 13(13) doi: 10.3390/diagnostics13132208
|
| 12 |
Masanari Kuwabara, Tomoko Fukuuchi, Yuhei Aoki, Einosuke Mizuta, Motoshi Ouchi, Masafumi Kurajoh, Tatsuya Maruhashi, Atsushi Tanaka, Nagisa Morikawa, Kensuke Nishimiya, Naoyuki Akashi, Yoshihiro Tanaka, Naoyuki Otani, Mihoko Morita, Hiroshi Miyata, Tappei Takada, Hiroshi Tsutani, Kazuhide Ogino, Kimiyoshi Ichida, Ichiro Hisatome, Kohtaro Abe. Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases. Biomolecules 2023; 13(10) doi: 10.3390/biom13101519
|
| 13 |
G. Chalès, G. Coiffier, F. Robin. Goutte et maladies cardiovasculaires. EMC - Appareil locomoteur 2025; 39(4) doi: 10.1016/S0246-0521(25)50672-1
|
| 14 |
Mariano Andrés. Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies. Gout, Urate, and Crystal Deposition Disease 2023; 1(3) doi: 10.3390/gucdd1030014
|
| 15 |
Pietro G. Lacaita, Andrea S. Klauser, Julia Held, David Haschka, Gerlig Widmann, Gudrun M. Feuchtner. Association between coronary monosodium urate deposits at DECT and high-risk coronary plaque phenotypes and other features in gout patients. European Radiology Experimental 2025; 9(1) doi: 10.1186/s41747-025-00611-z
|
| 16 |
Haolin Ren, Hang Qu, Yong Zhang, Yue Gu, Yi Zhao, Wenjuan Xu, Mingsheng Zhou, Wei Wang. Detection of monosodium urate depositions and atherosclerotic plaques in the cardiovascular system by dual-energy computed tomography. Heliyon 2024; 10(2) doi: 10.1016/j.heliyon.2024.e24548
|
| 17 |
Tomohiro Kaneko, Eitaro Kodani, Hitomi Fujii, Kenta Sugino, Yuri Kudo, Norihiro Shibasaki, Harufumi Ogino, Hiroyuki Nakamura, Hajime Sasabe, Yutaka Tamura, Masato Iwabu. Hyperuricemia accelerates renal dysfunction due to hypertensive nephrosclerosis: the TAMA MED Project-CKD. BMC Nephrology 2026; 27(1) doi: 10.1186/s12882-026-05012-x
|
| 18 |
Richard J. Johnson, Laura G. Sanchez Lozada, Miguel A. Lanaspa, Federica Piani, Claudio Borghi. Uric Acid and Chronic Kidney Disease: Still More to Do. Kidney International Reports 2023; 8(2) doi: 10.1016/j.ekir.2022.11.016
|
| 19 |
Chio Yokose, Sterling Ellis Eide, Florian A. Huber, F. Joseph Simeone, Brian B. Ghoshhajra, Kamran Shojania, Savvas Nicolaou, Fabio Becce, Hyon K. Choi. Frequently Encountered Artifacts in the Application of Dual‐Energy Computed Tomography to Cardiovascular Imaging for Urate Crystals in Gout: A Matched‐Control Study. Arthritis Care & Research 2024; 76(7) doi: 10.1002/acr.25312
|
| 20 |
Hyon K. Choi, Natalie McCormick, Chio Yokose. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nature Reviews Rheumatology 2022; 18(2) doi: 10.1038/s41584-021-00725-9
|
| 21 |
O. M. Drapkina, V. I. Mazurov, A. I. Martynov, E. L. Nasonov, S. A. Saiganov, A. M. Lila, R. A. Bashkinov, I. N. Bobkova, Ch. T. Baimukhamedov, I. Z. Gaidukova, N. I. Guseinov, D. V. Duplyakov, M. S. Eliseev, A. T. Mamasaidov, N. A. Martusevich, Kh. T. Mirakhmedova, I. T. Murkamilov, D. A. Nabieva, V. A. Nevzorova, O. D. Ostroumova, V. V. Salukhov, G. A. Togizbaev, E. A. Trofimov, Yu. Sh. Khalimov, A. I. Chesnikova, S. S. Yakushin. Consensus statement on the management of patients with asymptomatic hyperuricemia in general medical practice. Cardiovascular Therapy and Prevention 2024; 23(1) doi: 10.15829/1728-8800-2024-3737
|
| 22 |
Julia Held, David Haschka, Pietro G. Lacaita, Gudrun M. Feuchtner, Werner Klotz, Hannes Stofferin, Christina Duftner, Günter Weiss, Andrea S. Klauser. Review: The Role of Dual-Energy Computed Tomography in Detecting Monosodium Urate Deposits in Vascular Tissues. Current Rheumatology Reports 2024; 26(8) doi: 10.1007/s11926-024-01151-y
|
| 23 |
Oksana M. Drapkina, Vadim I. Mazurov, Martynov I. Martynov, Evgeny L. Nasonov, Sergey A. Saiganov, Aleksander M. Lila, Roman A. Bashkinov, Irina N. Bobkova, Chokan T. Baimukhamedov, Inna Z. Gaydukova, Nadir I. Huseynov, Dmitry V. Duplyakov, Maxim S. Eliseev, Abdimutalib T. Mamasaidov, Natalia A. Martusevich, Khilola T. Mirakhmedova, Ilkhom T. Murkamilov, Dildora A. Nabieva, Vera A. Nevzorova, Olga D. Ostroumova, Vladimir V. Salukhov, Galymzhan A. Togizbayev, Evgeny A. Trofimov, Iurii S. Khalimov, Anna I. Chesnikova, Sergey S. Yakushin. Consensus Statement on the Management of Patients With Asymptomatic Hyperuricemia in General Medical Practice. HERALD of North-Western State Medical University named after I.I. Mechnikov 2025; 17(1) doi: 10.17816/mechnikov676852
|
| 24 |
Byeong-zu Ghang, Ji Sung Lee, Jihye Choi, Jinseok Kim, Bin Yoo. Increased risk of cardiovascular events and death in the initial phase after discontinuation of febuxostat or allopurinol: another story of the CARES trial. RMD Open 2022; 8(2) doi: 10.1136/rmdopen-2021-001944
|
| 25 |
Masanari Kuwabara, Takahide Kodama, Ryusuke Ae, Mehmet Kanbay, Ana Andres-Hernando, Claudio Borghi, Ichiro Hisatome, Miguel A. Lanaspa. Update in uric acid, hypertension, and cardiovascular diseases. Hypertension Research 2023; 46(7) doi: 10.1038/s41440-023-01273-3
|
| 26 |
Anthony J. Amatucci, Lissa Padnick-Silver, Brian LaMoreaux, David H. Bulbin. Comparison Between Early-Onset and Common Gout: A Systematic Literature Review. Rheumatology and Therapy 2023; 10(4) doi: 10.1007/s40744-023-00565-x
|
| 27 |
Yue Zheng, Zhirui Chen, Jinya Yang, Jing Zheng, Xiaorong Shui, Yiguang Yan, Shian Huang, Zheng Liang, Wei Lei, Yuan He. The Role of Hyperuricemia in Cardiac Diseases: Evidence, Controversies, and Therapeutic Strategies. Biomolecules 2024; 14(7) doi: 10.3390/biom14070753
|
| 28 |
Ira Khanna, Venkatesh Mani, Renata Pyzik, Audrey Kaufman, Weiwei Chi, Emilia Bagiella, Philip Robson, Yousaf Ali. Assessing Changes in Vascular Inflammation and Urate Deposition in the Vasculature of Gout Patients After Administration of Pegloticase Using Positron Emission Tomography and Dual-Energy Computed Tomography—A Pilot Study. Gout, Urate, and Crystal Deposition Disease 2024; 2(4) doi: 10.3390/gucdd2040024
|
| 29 |
E. V. Panina, M. S. Eliseev. Prospects for prescription of urate-lowering therapy in patients with asymptomatic hyperuricemia and gout. Meditsinskiy sovet = Medical Council 2023; (21) doi: 10.21518/ms2023-404
|
| 30 |
Esther Ebstein, Sébastien Ottaviani. Managing Gout in Patients with Metabolic Syndrome. Drugs & Aging 2024; 41(8) doi: 10.1007/s40266-024-01132-x
|
| 31 |
Tristan Pascart, Jean-François Budzik. Does Monosodium Urate Crystal Vascular Deposition Exist? Review of the Evidence. Gout, Urate, and Crystal Deposition Disease 2023; 1(3) doi: 10.3390/gucdd1030017
|
| 32 |
Nicola Dalbeth, Mariam Alhilali, Peter Riordan, Ravi Narang, Ashika Chhana, Sue McGlashan, Anthony Doyle, Mariano Andres. Vascular deposition of monosodium urate crystals in gout: analysis of cadaveric tissue by dual‐energy computed tomography and compensated polarizing light microscopy. Arthritis & Rheumatology 2022; 74(7) doi: 10.1002/art.42066
|
| 33 |
Andrea S. Klauser, Sylvia Strobl, Christoph Schwabl, Werner Klotz, Gudrun Feuchtner, Bernhard Moriggl, Julia Held, Mihra Taljanovic, Jennifer S. Weaver, Monique Reijnierse, Elke R. Gizewski, Hannes Stofferin. Prevalence of Monosodium Urate (MSU) Deposits in Cadavers Detected by Dual-Energy Computed Tomography (DECT). Diagnostics 2022; 12(5) doi: 10.3390/diagnostics12051240
|
| 34 |
Tristan Pascart, Paul Carpentier, Hyon K Choi, Laurène Norberciak, Vincent Ducoulombier, Hélène Luraschi, Eric Houvenagel, Julie Legrand, Sébastien Verclytte, Fabio Becce, Jean-François Budzik. Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: The VASCURATE study. Seminars in Arthritis and Rheumatism 2021; 51(4) doi: 10.1016/j.semarthrit.2021.06.009
|
| 35 |
Janis Timsans, Antti Palomäki, Markku Kauppi. Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications. Journal of Clinical Medicine 2024; 13(24) doi: 10.3390/jcm13247616
|
| 36 |
P. A. Lebedev, S. V. Bulgakova, O. A. Gusyakova, E. V. Paranina. Hyperuricemia and NLRP3 inflammasome activity in the concept of metabolic syndrome and cardiovascular diseases. Experimental and Clinical Gastroenterology 2025; (3) doi: 10.31146/1682-8658-ecg-235-3-207-216
|
| 37 |
Valentina Nardi, Federico Franchi, Megha Prasad, Erica M. Fatica, Mariam P. Alexander, Melanie C. Bois, Josephine Lam, Ravinder J. Singh, Fredric B. Meyer, Giuseppe Lanzino, Yuning Xiong, Esther Lutgens, Lilach O. Lerman, Amir Lerman. Uric Acid Expression in Carotid Atherosclerotic Plaque and Serum Uric Acid Are Associated With Cerebrovascular Events. Hypertension 2022; 79(8) doi: 10.1161/HYPERTENSIONAHA.122.19247
|
| 38 |
Ru Liu-Bryan, Tracy Guo, Jennifer Lee, Robert Terkeltaub. Atherogenic Activation of Human Vascular Smooth Muscle Cells by Monosodium Urate Crystals. Gout, Urate, and Crystal Deposition Disease 2023; 1(3) doi: 10.3390/gucdd1030016
|